2024 ICD-10-CM Diagnosis Code I73.00

Raynaud's syndrome without gangrene

ICD-10-CM Code:
I73.00
ICD-10 Code for:
Raynaud's syndrome without gangrene
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Chronic
Code Navigator:

Code Classification

  • Diseases of the circulatory system
    (I00–I99)
    • Diseases of arteries, arterioles and capillaries
      (I70-I79)
      • Other peripheral vascular diseases
        (I73)

I73.00 is a billable diagnosis code used to specify a medical diagnosis of raynaud's syndrome without gangrene. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Drug-induced Raynaud's phenomenon
  • Isolated primary Raynaud's phenomenon
  • Occupational Raynaud phenomenon
  • Raynaud phenomenon due to autoimmune disease
  • Raynaud's disease
  • Raynaud's phenomenon
  • Raynaud's phenomenon
  • Raynaud's phenomenon
  • Raynaud's phenomenon
  • Raynaud's phenomenon due to trauma
  • Secondary Raynaud's phenomenon
  • Secondary Raynaud's phenomenon

Clinical Classification

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Convert I73.00 to ICD-9-CM

  • ICD-9-CM Code: 443.0 - Raynaud's syndrome
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Patient Education


Raynaud's Disease

Raynaud's disease is a rare disorder of the blood vessels, usually in the fingers and toes. It causes the blood vessels to narrow when you are cold or feeling stressed. When this happens, blood can't get to the surface of the skin and the affected areas turn white and blue. When the blood flow returns, the skin turns red and throbs or tingles. In severe cases, loss of blood flow can cause sores or tissue death.

Primary Raynaud's happens on its own. The cause is unknown. There is also secondary Raynaud's, which is caused by injuries, other diseases, or certain medicines.

People in colder climates are more likely to develop Raynaud's. It is also more common in women, people with a family history, and those over age 30.

Treatment for Raynaud's may include drugs to keep the blood vessels open. There are also simple things you can do yourself, such as:

  • Soaking hands in warm water at the first sign of an attack
  • Keeping your hands and feet warm in cold weather
  • Avoiding triggers, such as certain medicines and stress

NIH: National Heart, Lung, and Blood Institute


[Learn More in MedlinePlus]

Raynaud phenomenon

Raynaud phenomenon is a condition in which the body's normal response to cold or emotional stress is exaggerated, resulting in abnormal spasms (vasospasms) in small blood vessels called arterioles. The disorder mainly affects the fingers but can also involve the ears, nose, nipples, knees, or toes. The vasospasms reduce blood circulation, leading to discomfort and skin color changes.

Raynaud phenomenon is episodic, meaning that it comes and goes. A typical episode lasts about 15 minutes after the cold exposure or stressor has ended and involves mild discomfort such as numbness or a feeling of "pins and needles." The affected areas usually turn white or blue when exposed to cold or when emotional stress occurs, and then turn red when re-warmed or when the stress eases.

Raynaud phenomenon is categorized as primary when there is no underlying disorder that accounts for the exaggerated response of the blood vessels. It is called secondary when it is associated with another condition. Secondary Raynaud phenomenon is often associated with autoimmune disorders, which occur when the immune system malfunctions and attacks the body's own tissues and organs. Autoimmune disorders with which Raynaud phenomenon can be associated include systemic lupus erythematosus, scleroderma, rheumatoid arthritis, and Sjögren syndrome.

Primary Raynaud phenomenon is much more common and usually less severe than secondary Raynaud phenomenon. In severe cases of secondary Raynaud phenomenon, sores on the pads of the fingers or tissue death (necrosis) can occur. Primary Raynaud phenomenon often begins between the ages of 15 and 25, while secondary Raynaud phenomenon usually starts after age 30. Some people with Raynaud phenomenon alone later go on to develop another associated condition; regardless of which comes first, these cases are classified as secondary Raynaud phenomenon.


[Learn More in MedlinePlus]

Raynaud’s Phenomenon

Raynaud’s phenomenon is a condition that causes blood vessels to narrow, decreasing blood flow, usually in the fingers and toes.
[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.